Skip to main content

Oregon State Flag An official website of the State of Oregon »

Oregon Health Authority logo

Test Menu Details

SARS-CoV-2 Next Generation Sequencing (NGS)

Updated10/29/2026
Search TermsSARS-CoV-2 Sequencing; 2019 nCoV; COVID-19; surveillance; whole genome sequencing; WGS
How to OrderThis assay is not available for direct ordering. SARS-CoV-2 sequencing is performed for public health surveillance purposes as a reflex test according to the Respiratory Virus Testing Algorithm (pdf).
AvailabilityTesting is limited to specimens selected for public health SARS-CoV-2 surveillance based on epidemiological significance and laboratory capacity. Refer to the Respiratory Virus Testing Algorithm (pdf).
PerformedAs needed based on testing demand
Time to ReportingTurnaround time varies depending on specimen quality, testing demand, and sequencing capacity. Sequencing results are reported after initial SARS-CoV-2 results have been released.
Data SharingDe-identified data from SARS-CoV-2 sequencing are submitted to national and international repositories, GISAID or NCBI, to support genomic surveillance and epidemiological investigations data sharing. Additional details can be found in the COVID-19 Sequencing Educational Resources (pdf).
CPT Code

Specimen Collection Details

Specimen Details
All specimens will be co-tested for SARS-CoV-2 and influenza. Please refer to the Influenza SARS-CoV-2 Multiplex Real-Time RT-PCR Test Menu.

Qualifying SARS-CoV-2 positive specimens may undergo reflex sequencing if sufficient quality and quantity of viral nucleic acid are available. Specimen selection and testing priority are determined by epidemiological significance and laboratory capacity.


Method Details

MethodologyIon Torrent Ampliseq™ SARS-CoV-2 Insight Research Assay
Clear Labs Clear lx™ WGS SARS-CoV-2 v3.0 Assay
Performance
Specifications
The performance characteristics of this assay were evaluated by the OSPHL following the requirements for clinical laboratory testing established by the Clinical Laboratory Improvement Amendments (CLIA). This assay is intended for public health surveillance and infection control purposes. It should not be regarded as investigational or for research..

Ion Torrent AmpliseqSARS-CoV-2 Insight Research Assay:
Accuracy                           89.47%
Reproducibility                 100.00%
Sensitivity                         89.47%
Specificity                         100.00%

Clear lx™ WGS SARS-CoV-2:  
Accuracy                           96.97%
Reproducibility                  100.00%
Sensitivity                         96.20%

Specificity                         100.00%


Change Log

10/29/2026
Changes made throughout; review as new
2/19/2025Updated How to Order; Availability; Performed; Public Health Data; Handling